MABTECH
Mabtech develop, manufacture, and market monoclonal antibodies and kits suited for ELISA, ELISpot and FluoroSpot.
MABTECH
Industry:
Biotechnology Life Science Manufacturing Product Research Therapeutics
Founded:
1986-01-01
Address:
Nacka, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.mabtech.com
Total Employee:
11+
Status:
Active
Contact:
+46 8 716 27 00
Total Funding:
0
Technology used in webpage:
Domain Not Resolving Euro Amazon IPv6 Person Schema Facebook Sharer Pinterest Amazon SSL Amazon CloudFront Twitter Tweet Button
Similar Organizations
Jomar Life Research
Jomar Life Research provides antibodies, proteins, cytokines, assay kits, and accessories flow reagents.
Current Advisors List
![]()
Current Employees Featured

Founder
Investors List
EQT
EQT investment in Debt Financing - Mabtech
Mérieux Equity Partners
Mérieux Equity Partners investment in Private Equity Round - Mabtech
![]()
IK Investment Partners
IK Investment Partners investment in Private Equity Round - Mabtech
Official Site Inspections
http://www.mabtech.com Semrush global rank: 3.7 M Semrush visits lastest month: 3.76 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Mabtech"
Mabtech | Antibodies, ELISA, ELISpot, and FluoroSpot
Mabtech is a Swedish Biotech company focused on ELISpot, FluoroSpot, ELISA, and FociSpot kits and instruments. Spot your next discovery Antibodies and assays for understanding …See details»
Who we are - Mabtech
We are a Swedish company developing immunoassays for life science research. Our goal is to aid research by providing the scientific community with innovative tools, in particular for ELISpot, FluoroSpot, and ELISA.See details»
Sustainability | Mabtech
At Mabtech, sustainability is at the heart of our mission to drive innovation responsibly and ethically. We are dedicated to reducing our environmental footprint, advancing sustainable …See details»
Mabtech - Crunchbase Company Profile & Funding
Mabtech supplies a wide range of antibodies to cytokines, immunoglobulins and apolipoproteins. Mabtech may be growing as it has been acquired by EQT as …See details»
Mabtech - LinkedIn
We are a Swedish company developing immunoassays for life science research. Our goal is to aid research by providing the scientific community with innovative tools, in particular for ELISpot,...See details»
Mabtech - LinkedIn
We are a Swedish biotech company developing immunoassays for life science research. Our goal is to aid research, by providing the scientific community with innovative tools, in particular...See details»
Organization | Taizhou Mabtech Pharmaceutical Co., Ltd. - Purdue …
Taizhou Mabtech Pharmaceutical Co., ... Organization Overview. First Clinical Trial. 2017 NCT03206151. First Marketed Drug. None First NDA Approval. None Last Known Activity. …See details»
Mabtech - Merieux Partners
Mabtech is a Swedish biotech company that was founded by scientists at the Department of Immunology, Stockholm University. Since late 2019, the majority owners of Mabtech are IK …See details»
EQT introduces the EQT Healthcare Growth Strategy, a …
Jan 9, 2024 · Mabtech is a leading provider of high-quality antibody tools and kits, used predominantly for vaccine, infectious diseases, and oncology research, based in Sweden. EQT Healthcare Growth will support Mabtech as it expands …See details»
EQT Launches New Health-Care Growth Strategy and …
Jan 9, 2024 · Swedish private equity firm EQT AB is launching a health-care growth strategy, broadening its offering to cater to companies in every stage of their development.See details»
Leadership - Mabtech
Our board and management are as dedicated as our employees to drive Mabtech forward. Leadership A key feature is the efficient collaboration across all of our departments, facilitated by a shared view on customer satisfaction.See details»
Mabtech AB Company Profile | Nacka Strand, Stockholm, Sweden ...
Find company research, competitor information, contact details & financial data for Mabtech AB of Nacka Strand, Stockholm. Get the latest business insights from Dun & Bradstreet.See details»
Merieux Equity Partners and IK Partners to sell Mabtech to EQT
Jan 9, 2024 · Mabtech is a Swedish biotech company developing immunoassays for life science research. Since 1986, Mabtech’s mission has been to aid research by providing the global …See details»
Mabtech Company Profile - Office Locations, Competitors ... - Craft
Mabtech is a biotech company focused on monoclonal antibodies for ELISpot, FluoroSpot and ELISA kits and instruments. It develops and produces a range of monoclonal antibodies to …See details»
Mabtech - krishgenbiosystems.com
Mabtech is a Swedish biotech company developing immunoassays for life science research. Our goal is to aid research by providing the scientific community with innovative tools, in particular …See details»
Contact us - Mabtech
Phone: +46 8 716 27 00 General: [email protected] Orders: [email protected] Office hours: 9:00 am - 5:00 pm Organisation no: 556 276 - 8225 VAT no: SE556276822501See details»
Mabtech Company Profile 2024: Valuation, Funding & Investors
Developer of antibodies to cytokines, immunoglobulins and apolipoproteins intended to aid research by providing the global scientific community with efficient tools.See details»
IK Partners to sell Mabtech to EQT
Jan 9, 2024 · University, Mabtech is a global manufacturer of high-quality antibodies, kits and readers used to study immune responses, including those in cancer immunotherapies and …See details»
Sustainability report 2022 - Mabtech
At Mabtech, we prioritize continuous learning and growth, even if it means unlearning established practices Recently, during our materiality analysis to understand sustainability related risks …See details»
Ad26.RSV.preF completely protects calves from severe ... - Nature
3 days ago · Vaccination with Ad26.RSV.preF protects against severe or fatal respiratory illness induced by bRSV challenge. Animals were challenged with a dose of 6.3 × 10 3 TCID50 …See details»